Abstract
Metabolites of cerebrospinal biogenic amines (dopamine and serotonin) are an important tool in clinical research and diagnosis of children with neurotransmitter disorders. In this article we focused on finding relationships between the concentration of biogenic amine metabolites, age, and gender. We analyzed 148 samples from children with drug resistant seizures of unknown etiology and children with mild stable encephalopathy aged 0–18 years. A normal profile of biogenic amines was found in 107 children and those children were enrolled to the study group. The CSF samples were analyzed by HPLC with an electrochemical detector. The concentrations of the dopamine and serotonin metabolites homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), respectively, were high at birth, gradually decreasing afterward until the 18 years of age. Nevertheless, the HVA/5-HIAA ratio did not vary with age, except in the children below 1 year of age. In the youngest group we observed a strong relationship between the HVA/5-HIAA ratio and age (r = 0.69, p < 0.001). There were no statistical differences in the level of both dopamine and serotonin metabolites between boys and girls, although a trend toward lower HVA and 5-HIAA in the boys was noticeable. Significant inter-gender differences in the level of HVA and 5-HIAA were noted only in the age-group of 1–4 years, with 5-HIAA being higher in the girls than boys (p = 0.004). In conclusion, the study revealed that the concentration of biogenic amine metabolites is age and sex dependent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aitkenhead H, Heales SJ (2013) Establishment of pediatric age – related reference intervals for serum prolactin to aid in the diagnosis of neurometabolic conditions affecting dopamine metabolism. Ann Clin Biochem 50(Pt 2):156–158
Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, Goldman S (1996) Sex differences in 5HT2 receptor in the living human brain. Neurosci Lett 204(1–2):25–28
Blau N, Thony B, Cotton RG, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaduet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1725–1776
Blau N, Duran M, Blaskovics ME, Gibson KM (2005) Physician’s guide to the laboratory diagnosis of metabolic diseases, 2nd edn. Springer, Heidelberg
Dennis RL, Lay DC Jr, Cheng HW (2013) Effects of early serotonin programming on behavior and central monoamine concentrations in an avian model. Behav Brain Res 253:290–296
Duarte S, Sanmarti F, Gonzalez V, Perez Duenas B, Ormazabal A, Artuch R, Campistol J, Garcia-Cazorla A (2008) Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies. Brain Dev 30(2):106–111
Goldman-Rakic PS, Brown RM (1982) Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 4:339–349
Heales SJ (2008) Biogenic amines. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer, Berlin, pp 703–715
Hoffmann GF, Sutees RA, Wevers RA (1998) Cerebrospinal fluid investigation for neurometabolic disorders. Neuropediatrics 29:59–71
Hyland K (1999) Neurochemistry and defects of biogenic amine neurotransmitter metabolism. J Inherit Metab Dis 22:353–363
Hyland K (2006) Cerebrospinal fluid analysis in the diagnosis of treatable inherited disorders of neurotransmitter metabolism. Future Neurol 1(5):593–603
Hyland K, Surtees RA, Heales SJ, Bowron A, Howells DW, Smith I (1993) Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 34:10–14
Kandel ER, Siegelbaum SA, Schwartz JH (2000) Elementary interactions between neurons: synaptic transmission. In: Kandel ER, Schwartz JH, Jessel TM (eds) Principles of neural science. McGraw-Hill, New York, pp 123–134
Kurian MA, Gissen P, Smith M, Heales SJ, Clayton PT (2011) The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Neurology 10:721–733
Kusmierska K, Jansen EE, Jakobs C, Szymańska K, Małunowicz E, Meilei D, Thony B, Blau N, Tryfon J, Rokicki D, Pronicka E, Sykut-Cegielska J (2009) Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up. J Inherit Metab Dis 32(Suppl 1):S5–S10
Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC, Paul AI (2006) Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31:47–57
Montoya ER, Terburg D, Bos PA, van Honk J (2012) Testosterone, cortisol, and serotonin as key regulators of social aggression: a review and theoretical perspective. Motiv Emot 36:65–73
Ormazabal A, Artuch R, Vilaseca MA, Aracil A, Pineda M (2005) Cerebrospinal fluid concentration of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Neuropediatrics 5:380–385
Pearl PL, Hartka TR, Taylor J (2006) Diagnosis and treatment of neurotransmitter disorders. Curr Treat Options Neurol 8:441–450
Smith KM, Dahodwala N (2014) Sex differences in Parkinson’s disease and other movement disorders. Exp Neurol 259:44–56
Thomson BL, Stanwood GD (2009) Pleiotropic effects of neurotransmission during development: modulators of modularity. J Autism Dev Disord 39:260–268
Van Der Heyden JC, Rotteveel JJ, Wevers RA (2003) Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism. Eur J Paediatr Neurol 7:31–37
Van Goozen SH, Fairchild G (2006) Neuroendocrine and neurotransmitter correlates in children with antisocial behavior. Horm Behav 50:647–654
Verbeek MM, Blom AM, Wevers RA, Lagerwerf AJ, Van de Geer J, Willemsen MA (2008) Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations. Mol Genet Metab 95:127–132
Whitaker-Azmitia PM (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism. Int J Dev Neurosci 23:75–83
Acknowledgments
The study was supported in part by MNiSW grant N406 030 31/0915.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kuśmierska, K. et al. (2015). Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children. In: Pokorski, M. (eds) Advances in Clinical Science. Advances in Experimental Medicine and Biology(), vol 878. Springer, Cham. https://doi.org/10.1007/5584_2015_167
Download citation
DOI: https://doi.org/10.1007/5584_2015_167
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21496-2
Online ISBN: 978-3-319-21497-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)